Refine Results
  1. "Marc Ladanyi"
Formats
  1. Meeting Abstract (582)
  2. Journal Article (565)
  3. Book Section (13)
  4. Research Letter (6)
  5. Review (4)
  6. Editorial (3)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. GSK Faculty (1179)
  2. Human Oncology and Pathogenesis Program (1179)
  3. Department of Medicine (533)
  4. Solid Tumor Oncology Division (506)
  5. Thoracic Oncology (339)
  6. Surgery (266)

More Groups

People
  1. Marc Ladanyi (1179)
  2. Maria Arcila (256)
  3. Mark Kris (175)
  4. Michael Berger (168)
  5. Gregory Riely (162)
  6. Ahmet Zehir (152)

More People

Years
  1. 2022 (28)
  2. 2021 (61)
  3. 2020 (63)
  4. 2019 (95)
  5. 2018 (74)
  6. 2017 (52)

More Years

Publications
  1. Modern Pathology (181)
  2. Laboratory Investigation (150)
  3. Journal of Clinical Oncology (108)
  4. Journal of Molecular Diagnostics (83)
  5. Clinical Cancer Research (74)
  6. Cancer Research (65)

More Publications

Publishers
  1. Nature Publishing Group (207)
  2. Nature Research (182)
  3. American Association for Cancer Research (173)
  4. American Society of Clinical Oncology (123)
  5. Elsevier Science, Inc. (110)
  6. Elsevier Inc. (79)

More Publishers

Results (1179)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting mTOR and MEK or ERK inhibits the growth of PDX models of NF1-deficient pediatric sarcoma
    Meeting Abstract

    Lu, Y. C.; Odintsov, I.; Khodos, I.; Mattar, M.; Glade Bender, J.; Wexler, L.; de Stanchina, E.; Ladanyi, M.; Somwar, R.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Defining novel DNA virus-tumor associations and genomic correlates using prospective clinical tumor/normal matched sequencing data
    Journal Article

    Vanderbilt, C. M.; Bowman, A. S.; Middha, S.; Petrova-Drus, K.; Tang, Y. W.; Chen, X.; Wang, Y.; Chang, J.; Rekhtman, N.; Busam, K. J.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1-fusion-positive lung cancer
    Journal Article

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Siau, E.; Mattar, M. S.; de Stanchina, E.; Khodos, I.; Drilon, A.; Riely, G. J.; Ladanyi, M.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • Unexpected histologic and molecular features in tumors of long-term survivors (LTS) of diffuse pleural mesothelioma (DPM)
    Meeting Abstract

    Baine, M.; Adusumilli, P.; Bodd, F.; Ladanyi, M.; Offin, M.; Travis, W.; Yang, S. R.; Ventura, K.; Zauderer, M.; Sauter, J.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Histologic features of uterine leiomyosarcomas clinically profiled by targeted DNA-based next generation sequencing
    Meeting Abstract

    Riviere, S.; Boroujeni, A. M.; Hensley, M.; Ladanyi, M.; Ellenson, L.; Chiang, S.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Large scale genomic and clinicopathologic analysis of SWI/SNF-deficient undifferentiated malignancies of the gynecologic tract
    Meeting Abstract

    Tessier-Cloutier, B.; Ladanyi, M.; Soslow, R.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Genomic landscape analysis of ERBB3-mutated human cancers reveals common co-occurrence with activating ERBB2 alterations
    Meeting Abstract

    Odintsov, I.; Somwar, R.; Ladanyi, M.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Unexpected histologic and molecular features in tumors of long-term survivors (LTS) of diffuse pleural mesothelioma (DPM)
    Meeting Abstract

    Baine, M.; Adusumilli, P.; Bodd, F.; Ladanyi, M.; Offin, M.; Travis, W.; Yang, S. R.; Ventura, K.; Zauderer, M.; Sauter, J.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Genomic landscape analysis of ERBB3-mutated human cancers reveals common co-occurrence with activating ERBB2 alterations
    Meeting Abstract

    Odintsov, I.; Somwar, R.; Ladanyi, M.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save